575 MADISON AVENUE, NEW YORK, NY
Chief Medical Officer Resignation - Anna Eramo Steps Down
2026 Annual Meeting Results - Directors Elected at LB Pharmaceuticals
Reports First Quarter 2026 Financial Results and Provides Corporate Update
Annual Report to Security Holders
Financial Results, Press Release
Director Retirement - Zachary Prensky to Step Down from Board
Appoints R&D Biotech Executive Robert Lenz, M.D., Ph.D. to Board of Directors
Announces $100.0 Million Private Placement
Q1
Q3
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
S-1
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(4)
Additional Proxy Materials
Definitive Proxy Statement
Notice of Proposed Sale of Securities
Statement of Changes in Beneficial Ownership
S-1MEF